TPD & Induced Proximity Summit Leaderboard
  • Thursday, July 9, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 597

Alnylam Announces FDA Granted Priority Review of the Givosiran NDA for the Treatment of Acute…

Aug 5, 2019
Alnylam Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for givosiran, an investigational RNAi…
Read More...

2nd Annual Pharma Packaging, Labelling, Serialisation, Track and Trace 2019

Aug 5, 2019
2nd Annual Pharma Packaging, Labelling, Serialisation, Track and Trace 2019 “Securing your Supply Chain and Quality Management” 19th September 2019, Kohinoor Continental Hotel,…
Read More...

Telix Pharmaceuticals and German Cancer Research Center (DKFZ) Enter into Collaboration and Option…

Aug 5, 2019
Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or…
Read More...

FDA Approves Daiichi Sankyo’s TURALIO (pexidartinib) for the Treatment of Select Patients with…

Aug 5, 2019
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the U.S. Food and Drug Administration (FDA) approved TURALIO (pexidartinib) as the first and only treatment…
Read More...

Omeros and Lonza Enter Long-Term Manufacturing Agreement for Commercial Supply of Narsoplimab

Aug 2, 2019
Omeros Corporation announced a long-term manufacturing agreement for commercial production of narsoplimab, Omeros’ lead human monoclonal antibody targeting mannan-binding…
Read More...

LSNE Announces Expansion Of Controlled Temperature Storage Services At LSNE-Bedford

Aug 2, 2019
Lyophilization Services of New England (LSNE), a leading contract development and manufacturing organization, continues their expansion with the addition of increased cGMP storage…
Read More...

Samsung BioLogics and UCB Sign Third Drug Manufacturing Deal

Aug 2, 2019
Samsung BioLogics (SBL) and UCB have agreed to an additional drug substance manufacturing deal under which SBL will also produce UCB's anti-tau candidate to treat progressive…
Read More...

FDA approves Bayer’s Nubeqa (darolutamide), a new treatment for men with non-metastatic…

Aug 2, 2019
The U.S. Food and Drug Administration (FDA) approved Nubeqa (darolutamide), an androgen receptor inhibitor (ARi), for the treatment of patients with non-metastatic castration-resistant…
Read More...

Pfizer Announces Closing of Joint Venture With GlaxoSmithKline to Create a Premier Global Consumer…

Aug 2, 2019
Pfizer Inc. announced the closing of its joint venture with GlaxoSmithKline plc to combine the parties’ respective consumer healthcare businesses to create the world’s largest…
Read More...

Endo Appoints Domenico Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and…

Aug 1, 2019
Endo International plc announced the appointment of Domenic Ciarico as Executive Vice President and Chief Commercial Officer, Sterile and Generics, effective immediately. In this…
Read More...
Previous 1 … 595 596 597 598 599 … 938 Next
RNA-Based Therapeutics & Vaccines Summit South Korea
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
Cell & Gene Therapy Summit South Korea
10th Dermatology Drug Development Summit
9th Lab Asset & Facility Management Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Evogene, Tel Aviv University Launch AI Drug Discovery Initiative
  • Wainua Misses Primary Endpoint in ATTR-CM Phase III Trial
  • Cyllene Raises €33m to Advance Neurogenic Bladder DNA Medicine
  • Biocytogen and Whitehawk Partner on Bispecific ADC Development
  • FDA Grants Rare Pediatric Disease Status to Vanda’s CMT2S Therapy

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.